These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32924697)

  • 1. Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users.
    El-Ma'aita A; Da'as N; Al-Hattab M; Hassona Y; Al-Rabab'ah M; Al-Kayed MA
    J Int Med Res; 2020 Sep; 48(9):300060520955066. PubMed ID: 32924697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.
    Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K
    J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates.
    Sobczak-Jaskow H; Kochańska B; Drogoszewska B
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374277
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
    Supanumpar N; Pisarnturakit PP; Charatcharoenwitthaya N; Subbalekha K
    PLoS One; 2024; 19(1):e0297500. PubMed ID: 38277387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical students' knowledge of medication related osteonecrosis of the jaw.
    Franchi S; Brucoli M; Boffano P; Dosio C; Benech A
    J Stomatol Oral Maxillofac Surg; 2020 Sep; 121(4):344-346. PubMed ID: 31672685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate Induced Osteonecrosis of the Jaws: Our Clinical Experience at King Hussein Medical Center, Amman, Jordan.
    Al-Rabadi H; Daklalah LK; Alwreikat M; Alqudah M; Momani M; Nsour HF
    J Contemp Dent Pract; 2018 Nov; 19(11):1400-1403. PubMed ID: 30602648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness About Medication-Related Osteonecrosis of the Jaw Among Dental Professionals: A Multicentre Study.
    Patil V; Acharya S; Vineetha R; Nikhil K
    Oral Health Prev Dent; 2020 Jul; 18(3):505-509. PubMed ID: 32016175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
    Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
    Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
    Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
    Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical and Dental Professions' Varying Levels of Awareness Regarding Medication-related Osteonecrosis of the Jaw in Saudi Arabia? A Cross-sectional Study.
    Aljohani MH; Aljohani AS; Aljohani RM; Alsharif WK; Nourwali I; Elsayed SA
    J Contemp Dent Pract; 2024 Jan; 25(1):62-67. PubMed ID: 38514433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
    Yang G; Williams R; Wang L; Farhadfar N; Chen Y; Loiacono AT; Bian J; Holliday LS; Katz J; Gong Y
    J Bone Miner Res; 2022 Dec; 37(12):2466-2471. PubMed ID: 36151778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T; Bryant C; Popat S
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and Attitude among Physicians Regarding Bisphosphonaterelated Osteonecrosis of the Jaw (BRONJ): A Cross-sectional Study.
    Priyadarshini V; Ramachandra SS; Ganganna A
    Curr Drug Saf; 2023; 18(3):361-367. PubMed ID: 35570536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dentist's Perspective on the Need for Interdisciplinary Collaboration to Reduce Medication-Related Osteonecrosis of the Jaw.
    Griffin A; Brain P; Hancock C; Jeyapalina S
    Sr Care Pharm; 2022 Sep; 37(9):458-467. PubMed ID: 36038998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.